238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Analyze DCF forecasts for the company and compare them with competitors.
282.84B
Better than META's revenue of 116.61B.
9.78%
Better than META's revenue growth rate of -1.12%.
91.33B
Better than META's ebitda of 42.24B.
32.29%
Worse than META's ebitda margin of 36.22%.
77.86B
Better than META's ebit of 33.55B.
27.53%
Worse than META's ebit margin of 28.78%.
13.47B
Worse than META's depreciation of 8.69B.
113.76B
Better than META's total cash of 40.74B.
40.22%
Better than META's cash as percentage of revenue of 34.94%.
40.26B
Worse than META's receivables of 13.47B.
14.23%
Worse than META's receivables as percentage of revenue of 11.55%.
2.67B
Worse than META's inventories of 0.00.
0.94%
Worse than META's inventories as percentage of revenue of 0.00%.
5.13B
Worse than META's accounts payable of 4.99B.
1.81%
Better than META's payables as percentage of revenue of 4.28%.
-31.48B
Better than META's capital expenditure of -31.43B.
-11.13%
Worse than META's capex as percentage of revenue of -26.95%.
9.08%
Better than META's weighted average cost of capital (wacc) of 9.85%.
9.14%
Better than META's cost of equity of 9.99%.
4.26%
Equal to META's cost of debt of 4.26%.
1.03
Better than META's beta of 1.22.
12.72B
Worse than META's diluted shares outstanding of 2.63B.
28.50B
Better than META's total debt of 37.23B.
2.49T
Better than META's total equity of 1.63T.
2.51T
Better than META's total capital of 1.66T.
1.13%
Better than META's debt weighting of 2.24%.
98.87%
Better than META's equity weighting of 97.76%.
65.46B
Better than META's ebiat of 27.01B.
44.09B
Better than META's unlevered free cash flow of 5.75B.
4.00%
Equal to META's long-term growth rate of 4.00%.
2.32T
Better than META's terminal value of 878.04B.
1.82T
Better than META's enterprise value of 681.42B.
4.46B
Worse than META's net debt of -4.63B.
1.81T
Better than META's equity value of 686.05B.
142.34
Worse than META's equity value per share of 260.96.
View analysts' price targets and recommendations, and compare them with competitors.
$187.00
Has downside compared to META's upside of 12.49%.
Buy
Equal to META's analyst recommendation of Buy.
Analyze analyst forecasts for the company and compare them with competitors.
27.51B
No peer data available for comparison.
11.43B
No peer data available for comparison.
0.66
No peer data available for comparison.
7.96B
No peer data available for comparison.
9.74B
No peer data available for comparison.
4.46B
No peer data available for comparison.
